🔎 Trials Near Me

Dachaigh › Siostam Immune agus Galaran › Utah › Salt Lake City

Sgrùdaidhean clionaigeach Siostam Immune agus Galaran ann an Salt Lake City, UT

Tha 5 sgrùdaidhean airson Siostam Immune agus Galaran a’ lorg phàirtichean aig làraichean ann agus timcheall air Salt Lake City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

A’ fastadhÌre 2
  • Huntsman Cancer Institute - University of Utah Health, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT04996875

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

A’ fastadhÌre 1/2
  • Huntsman Cancer Institute, Salt Lake City
  • Intermountain Healthcare, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

A’ fastadhÌre 1/2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT03328078

Study of Gastric Motility in Eosinophilic Gastritis

A’ fastadhSgrùdadh amharc
  • University of Utah, Salt Lake City
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 31 Màrt 2026 · NCT05229432

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

A’ fastadhÌre 2
  • Intermountain Health, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Dùbh 2025 · NCT06619561

Sgrùdaidhean Siostam Immune agus Galaran ann am bailtean eile

Sgrùdaidhean eile ann an Salt Lake City

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.